chrisvoncsefalvay/vaers-outcomes huggingface dataset:
On 25Jan2021 tested positive for COVID; On 25Jan2021 tested positive for COVID; Headache; Loss of appetite; Dry skin patches; This is a spontaneous report from a Contactable Consumer (patient) via a Pfizer-sponsored program. A 50-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 08Jan2021 18:00 at single dose in left arm for COVID-19 immunization. Medical history and concomitant medications were none. The patient had no Prior Vaccinations within 4 weeks. The patient took the first dose of the COVID vaccine on 08Jan2021 and was due to get his second dose but on 25Jan2021 tested positive for COVID. The patient wanted to know if he was allowed to take the second dose. He had a PCR nasal swab that showed the positive COVID diagnosis. He took headache medication after, Tylenol. He had a headache starting on 21Jan2021 and it was lingering on and off but has resolved at this point. He noticed about 8-9 pm the night he got the shot, 08Jan2021, on both feet he had dry skin patches and this lasted about 2 hours; it resolved as this point. He also had a loss of appetite the next day though he ate anyway. That lasted about 8 hours. The outcome of Loss of appetite, Dry skin patches, Headache was resolved. The outcome of other events was unknown.  Information about Lot/ Batch has been requested.
Hives around various parts of body that still have not gone away.  Similar situation occurred a year ago after receiving Moderna booster as well.
Severe chills, violently shaking.   Body aches. Fever of 103.   First night.  Second night body aches and severe sinus pain.   Diarrhea and nausea.  Lasted 4 days.
ASTHMA  ISSSUES AND TACHACARDIA LASTING 4-5 HORSHRT RATE BETWEEN 118--130, HEAVINES IN CHEST
No additional AE; A pregnant patient received a GARDASIL 9 vaccine; She was supposed to be receiving the flu vaccine; This spontaneous prospective pregnancy report as received from a registered nurse refers to a 32-year-old pregnant female patient. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided.      On 26-JAN-2021, the patient was vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9), 0.5 milliliter, once (route of administration, anatomical location, lot # and expiration date were not reported) for prophylaxis. She was supposed to be receiving the influenza virus vaccine (unspecified)  (exact dose, route of administration, anatomical location, lot # and expiration date were not reported) for prophylaxis. The patient's gestation period was 9 weeks 4 days, the pregnancy outcome was pending, and the fetal outcome was unknown.
Information has been received from a RN concerning a 4 year old female who on 03Mar2000 was vaccinated SC with a first dose of varicella virus vaccine live. On 15Oct2003 the pt experienced varicella with 36 lesions. "one week later" the pt recovered. Additional information has been requested.
Pt reported signs of hives on left arm at crease of elbow and on inner thighs. Pt reported symptoms approximately 3 hours after vaccination administration.
Returned within 30 min, mother stated "she is breaking out all over". Pt had servere hives all over torso and spreading up to neck & ears. Tx'd w/Epinephrine. Mother stated that she had already given Benadryl in the car. Excellent results.
One hour after vaccine started getting muscles twitching and cramping. That night got fever, chills, sweating. Took ibuprofen. Next day vomiting. On second day swollen lip. No fever, no breathing problems. Seen by doctor on Aug. 20th. Still had diarrhea and some arm twitching. Advised by doctor she should not repeat vaccine unless done in hospital setting.
Noted yesterday afternoon to have erythema and firmness at the injection site. Local reaction more likely, plan is to check status tomorrow. VAERS report.
pt states that 2wk p/vax pt devel a red rash @ the inj site including 2 red blisters;c/o malaise, fever up to 101 & a total of 20 pimple lesions in random pattern;
At 0905, Pt c/o heart palpitations, felt lightheaded, dizziness, and R knee felt tight. At the back of the head, felt pulsating like his heartbeat. Transferred to private monitoring room, to gurnee. Lowered hob to 30 degrees. Heart rate: 71, BP 156/90, Resp 20, Puse ox 97%  At 0915, BP 136/86/ heart rate 72, pulse ox 97%. Pt states his head is starting to feel better, but knee remains feeling tight. Denies heart palpitations now.   At 0925 NBP 138/87, heart rate 64 pulse ox 96%.   At 0927, sitting at edge of bed without complaints: BP 133/88, heart rate 78. Pulse ox 98%. Still c/o feeling lightheaded. R knee remains tight.  At 0930, still light headed, but with  R side of head felt heavy. Lighter on L side of head. Knee improving significantly.  Patient states he feels well enough to return home.  Pt returned home
Very bad headache after 30 mins .  Around 4 hours later I started to itch, face tingling , tongue tingling , extreme nausea . Dizziness . These symptoms continued for 3 days . Headache lasted 6 days
Two hours after vaccination, pt experienced dizziness, lightheadedness, and chills. Fever 100 deg F. Pt took allergy sinus med. Laid down and slep all afternoon. Woke up 5pm, neck very stiff, could not move, very noticeable on right side of neck
Edema, pain, induration - improving.  Treated with Indocin, Benadryl, APAP, Cold packs.
I have diabetes too; I have verry hight sugar; I feel strange, without power.; The diabetes was... fatal.. verry bad.; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. Other Case identifier(s): MOD-2022-626780 (Mderna).  A patient (no qualifiers provided) received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DIABETES MELLITUS (medically significant), outcome "unknown", described as "I have diabetes too"; BLOOD GLUCOSE INCREASED (non-serious), outcome "unknown", described as "I have verry hight sugar"; FEELING ABNORMAL (non-serious), outcome "unknown", described as "I feel strange, without power."; DRUG INTERACTION (non-serious), outcome "unknown", described as "The combinacion con diabetes was... fatal.. verry bad.".  Clinical course: The attached reports concerning your product, PFIZER/BIONTECH VACCINE , was being forwarded to Pfizer on behalf of Moderna in compliance with the FDA regarding post-marketing adverse event reporting dated Mar1992 and posted 1998. Please be informed below provided email contains information of other manufacturer. Hence, Forwarded it to pifzer. Case created with system ID MOD-2022-626780. Kindly find the response received from the reporter upon follow-up for the case: MOD-2022- 626780.  Yes, Patient had verry high sugar (Patient had diabetes too).., Patient feel strange, without power.. After patient make Pfizer.. Now patinet try to recuper patient healed.. The combination with diabetes was... fatal.. very bad.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
morbilliform rash noted on abdomen, chest, and back on 4/11/21 5am (37 hours post vaccination) Tmax 99.9 on 4/10 8pm (28 hours post vaccination) morbilliform rash was also noted about 1 day after the first vaccine four weeks earlier. duration of rash post 1st dose was ~3 days.
Right arm with raised area about the size of a baseball, red and hot to touch. Started on 1/9/03 PM and continued through to 1/12/03.
Loss of appetite, fatigue, malaise. One week later, 01/21/21 raised, red, itchy, rash appeared at injection site, lasted until 01/25/21
This spontaneous report as received from a healthcare worker (office manager) and from medical assistant refers to a patient of unknown age and gender who on 02-APR-2015 was vaccinated with improperly stored GARDASIL (dose, lot #, expiration date and route were not reported). No symptoms were reported (no adverse event). It was unknown if the patient sought medical attention. This is one of several reports from the same source. Additional information is not expected because there is not permission for the physician to be contact.
Wakeup with (rt) arm hurting, later woke up again with nausea, and headache.
pt did not feel ill or had mild symptoms after 2nd dose of vaccine.  4 days later patient developed fever of 101 and not controlled with acetaminophen.  Temp increased to 103 and patient taken to ER and then diagnosed with pulmonary embolism.  Patient still hospitalized.  Not sure if related to vaccine.
I had tingling of my tongue and soreness in my upper and lower pallet of my mouth.
This spontaneous report was received from a non-healthcare professional (office administrator) regarding a 4 month old female patient. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 25-JUN-2018 the patient was vaccinated with expired dose of oral, ROTATEQ lot # M045375 with expiration date: 24-JUN-2018 orally for prophylaxis (expired product administered). No adverse effects were reported.
Information has been received from a nurse referring to a 21 month old patient of unknown gender. On 24-FEB-2016 the patient was vaccinated with the first dose of (Oka/Merck) VARIVAX that was improperly stored (dose and route were not reported). It was not specified the lot # was L034370 (expiration date 08-SEP-2017) or L013063 (expiration date 14-APR-2017). The vaccine was exposed to temperature max -4 degree for 2 hours. There was no previous temperature excursion. No adverse effects were reported. Additional information has been requested.
pt recv vax & devel wild type chickenpox about 12 to 10 days PTA now afeb pox illness face-trunk- red pap vesicles & early pustules;
This spontaneous report as received from a Registered Nurse who stated that she heard from an unspecified person that "a bunch of patients at an unspecified nursing home were administered ZOSTAVAX (dose, route and lot # were unknown) on unspecified dates and developed shingles about 10-15 days after ZOSTAVAX administration". The outcome of event unknown. The action taken of ZOSTAVAX and relationship between event were unknown. Attempts are being made to verify the existence of the patients and to obtain patients identifier. Additional information has been requested.
This spontaneous report was received from a pharmacist refers to a 59 years old female patient of unknown age. No drug reactions or allergies was reported. On 05-SEP-2014 the patient was vaccinated with ZOSTAVAX vial 19400 PFU (dosing regimen unspecified) (Lot # K003602, expiry: March 2015) for to prevent shingles. Concomitant therapies included methotrexate, omeprazole, folic acid and vitamin D (unspecified). Approximately on an unknown date in September 2014 (also reported as after vaccination) the patient experienced itchy rash after receiving ZOSTAVAX. No treatment was given. No lab tests performed. Patient sought medical attention and contacted pharmacist. There was no product quality complaint (PQC) involved. The outcome of itchy rash is unknown. Causality assessment was not reported. Additional information has been requested.
Patient experienced chills, fever, muscle pain, and fatigue as well as a large 4 inch red area at the injection site.
There was no patient adverse effect noted.  Patient came into our remote vaccine clinic requesting a Covid booster.  She stated her last booster was a year ago.  After giving her the Pfizer bivalent booster per her request,  she presented her vaccine card which had a prior Pfizer bivalent dose which was given on 10/6/22.  When I asked her about it, she stated "Oh my gosh, Yes I forgot that I received that."
Since getting this vaccine I?ve been experiencing random, completely unexpected shortness of breath. I could be sitting down watching tv and I?ll get a random shortness of breath. I?ve never experienced this prior to this vaccine.
Specialist transferred physician who is requesting guidance on use of MMRII after a 21 month old patient experienced an unspecified rash. She states that she has already swabbed the "measle like rash." She also states that the patient had a fever. Sh; fever; This spontaneous report was received from a physician and refers to a 21-month-old patient of an unknown gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On an unknown date, the patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX), with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) both for prophylaxis (strength, dose description, lot #, expiry date, and route of administration were not provided for both); and with hepatitis a vaccine, (strength, formulation, dose description, lot #, expiry date, route of administration, and indication were not provided). On the same day, the patient experienced unspecified rash, she swabbed the "measle like rash" and also experienced a fever. The outcome of the events was nor provided. Relatedness between the events and suspect vaccines was not reported.
Systemic: Allergic: Difficulty Breathing-Medium, Systemic: Allergic: Difficulty Swallowing, Throat Tightness-Medium, Systemic: Allergic: Swelling of Face / Eyes / Mouth / Tongue-Medium, Additional Details: Patient immediately experience throat feeling tight and tongue feeling thick/full. referred pt to ED.
Arm pain and weakness. Biceps tendonitis. Stretching exercises, ice, NSAIDs.
Pt c/o roof of mouth and tingling tongue. Pt c/o racing heart and sweaty palms. Pt was observed from 1:25pm-2pm when she stated that she was ok and wanted to go. Pt was initially offered 911 transport but declined. Pt then went to her car and felt worse. Re presented to the clinic and then 911 was initiated.
This spontaneous report was received from a registered nurse regarding an unspecified number of patients of unknown age. There was no information about concurrent condition and historical medication. On an unknown date the patients were vaccinated with a total of 5 doses (unspecified in series) of improperly stored VAQTA, lot no. L048460, expiration date-14-JAN-2017. No concomitant medication was reported. No adverse event was reported. The outcome of the event was unknown. Temperature was 58 F, time frame was 72 hours, there was no previous temperature excursion and call was because of data logger. No PQC (product quality complaint) was involved. This is one of several reports received from the same reporter. Additional information has been requested.
This spontaneous report as received from a other health professional refers to a unspecified number of patients of unknown age and gender. Medical history and concurrent conditions were not reported. On 14-FEB-2015, unspecified number of patients were vaccinated with improperly stored doses of ZOSTAVAX lot number reported as K021953, expiration date 10-FEB-2016. Dose and route were not reported. No co-suspect and concomitant therapies were reported. No adverse events reported. This is one of several reports from the same source. Additional information has been requested.
Received J&J vaccine on 04/28/2021. She had no adverse reaction. Approximately 48 hours post Moderna booster on 12/22/2021, skin began to tingle and itch, developing into hives. Upon administration of diphenhydramine, symptoms subsided only to return hours later. It persisted for 6 days, accompanied by joint pain/swelling of fingers and toes.
Sick; Sore throat; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Sick) and OROPHARYNGEAL PAIN (Sore throat) in an elderly female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product UPADACITINIB (RINVOQ) tablet for Rheumatoid arthritis.    No Medical History information was reported.   On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 19-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient started UPADACITINIB (RINVOQ) (Oral) 15 milligram once a day. On an unknown date, the patient experienced ILLNESS (Sick) and OROPHARYNGEAL PAIN (Sore throat). At the time of the report, ILLNESS (Sick) and OROPHARYNGEAL PAIN (Sore throat) outcome was unknown.            No concomitant medication were provided.  There was no reported medical history. It was unknown if patient was enrolled in a COVID-19 Vaccine Trial.  No treatment details were provided
Rash & UrticariaPruritus Narrative:  Quarter sized circular area of swelling around injection site. Developed ~1 day after and lasted for another ~2 days. Described as raised, erythematous, pruritic, indurated. Area developed ecchymosis after resolution of these issues. No associated hives, sloughing or other adverse effects noted. No therapies tried or applied.
Reactivation of latent Epstein-Barr Virus infection confirmed by elevated titers.
get the flu; Initial information received on 20-Nov-2020 regarding an unsolicited valid non-serious case from a patient via social media.  This case involves a patient of unknown demographics who got the flu (influenza) about a month or so later, when the patient received vaccine Influenza Vaccine.  The patient's medical history, past medical treatment(s), vaccination(s), concomitant medications and family history were not provided.   On an unknown date, the patient received an unknown dose of suspect influenza vaccine produced by unknown manufacturer (lot number, route, administration site and expiry date not reported) for prophylactic vaccination.  On an unknown date, the patient got the flu (influenza), about a month or so later following the administration of influenza vaccine.  No relevant laboratory test was reported.  It was not reported if the patient received a corrective treatment.  The event outcome was unknown at the time of reporting.  There will be no information available on the batch number for this case.
When I receive my first shot, I immediately felt a tingling and a numbness that travelled down my arm. It lasted for the next couple days of lessening severity, and through the next week. My arm was also extremely sore. I also had additional symptoms for the next few weeks. Now in that hand and arm I have pain that feels like a shooting pain / cramping, it comes and goes now that is new, and occasionally feel a numbness and tingling in that hand / arm but it is not consistent / all the time. I never experienced anything like this prior to getting the shot or had issues with my hands and arms like this.
Vaccine administered (0.25 dose) on 10/28/21 at 8:55am with an expired Vial: Expiration date 10/27/21 11:59pm.
The pt experienced fatigue, fever, erythematous papular rash, central vesicles with itching for 2 days. Clinical illness consistent with mild varicella.
PNEUMOVAX given on 11/2/2010. Pt. reported extreme soreness with swelling and redness in area of shot started on 11/3/10. Contacted office on 11/4/10 and was brought in to be seen. Area was red, slightly swollen, & sore to touch. Treated with antibiotics and prednisone.
Information has been received from a medical assistant concerning an 11 year old patient who vaccinated with a dose of VARIVAX (Merck). On an unknown date the patient broke out in a rash under the arms and face. The patient's IgM was 0.49 and IgG was 2.94. It was reported that a culture was done with unknown results. The patient's final outcome was not reported. Follow up information received on 08-MAY-2009 from the medical assistant stated that the patient was vaccinated with a first and second doses of VARIVAX (Merck). The patient broke out in rash after receiving both doses. Follow up information has been received from a medical assistant concerning a 11 year old female patient with no pertinent medical history of no known drug allergies, who on 17-APR-2009 at 3:20 pm, was vaccinated with the second dose of VARIVAX (Merck) (Lot: 659604/1743X) subcutaneously in the left deltoid and MENACTRA (Lot: a2869AA) intramuscularly in the left deltoid. On 03-MAY-2009 the patient developed rash on face and axilla, which looks like varicella. But culture was positive for measles, viral culture was negative and Varicella zoster IgM was negative. On 04-MAY-2009 at 14:13 hours the patient underwent a Minimum Inhibitory Concentration (MIC), of skin with amoxacillin/clavulanate <=4/2, ampicilin/sulbactam <=8/4, ceftriaxone 8, cefazolin <=8, clindamycin <=0.25, Levofloxacin <=0.5, trimethoprim/sulfamethoxazole <=0.5/9.5, vancomycin 1, oxacillin >2, erythromycin >4. An aerobic/anaerobic culture was conducted on skin and a gram stain showed no WBC seen, no organism seen. The anaerobic culture showed no growth after 48 hours, and the aerobic culture Methicillin resistant S. aureus, quan and heavy growth, a Varicella zoster IgG test showed 2.94 and Varicella zoster IgM test showed 0.49. Finally no virus were isolated in a viral culture from a lesion. The patient was treated then with BACTRIM (suspension) 2 teaspoon oral twice a day for 10 days and BACTROBAN (Ointment) to apply twice on lesion for 5 days. The physician stated that appeared not to be related to vaccine. On an unspecified date the patient recovered. No further information is expected.
CANCER IN THEIR BODY AND NEED SURGERY; This spontaneous report received from a consumer via a company representative via media concerned multiple patients. The patient's weight, height, and medical histories were not reported. The patients previously received covid-19 vaccine ad26.cov2.s (Dose number in series 1) (suspension for injection, route of admin, batch number and expiry were not reported) dose, start therapy dates were not reported, 01 total administered for covid-19 prophylaxis.  On an unspecified date, the patients experienced cancer in their body and need surgery following vaccination with first dose of covid-19 vaccine ad26.cov2.s (Dose number in series 1). The outcome of cancer in their body and need surgery was not reported. The patients additionally received covid-19 vaccine ad26.cov2.s (Dose number in series 2) (suspension for injection, route of admin, batch number and expiry were not reported) dose, start therapy dates were not reported, 01 total administered for covid-19 prophylaxis. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported.  On an unspecified date, the patients experienced cancer in their body and need surgery after taking these Covid shots and boosters (Dose number in series 2). As per the reporter, "as a result of these covid shots and boosters there are a lot of people we have talked to at the hospital that "surprising now have cancer" in their body and need surgery after taking these Covid shots and boosters. It is all the makers of this covid shot not sure about JJ." The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of cancer in their body and need surgery was not reported. This report was serious (Other Medically Important Condition). This case, involving the same patient is linked to 20221123551 (Dose number in series 1). This case, from the same reporter is linked to 20221123504 and 20221124203.; Sender's Comments: V0: 20221123543- Cancer in their body and need surgery. Insufficient information is available to make a causality assessment. Therefore, this event is considered unclassifiable.
Within 6 hours; fever, chills, aches and pains, insomnia. Fever lasted about 36 hours. Exhaustion. Very incapacitating.